Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS2403816	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2024-11-08		Chengdu Shengnuo Biopharm Co Ltd			view
CYHS2403534	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2024-10-18					view
CYHS2403334	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2024-10-09		Double-Crane Pharmaceutical(Hainan) Co Ltd			view
CYHS2402190	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2024-07-16		Sichuan Gowell Pharmaceutical Co Ltd			view
CYHS2302540	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2023-09-20					view
JYHZ2300221	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	License Renew	2023-05-11					view
JYHZ2300222	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	License Renew	2023-05-11					view
CYHS2300919	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2023-03-28		Qilu Pharmaceutical (Hainan) Co Ltd			view
CYHS2300918	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2023-03-28		Qilu Pharmaceutical (Hainan) Co Ltd			view
JYHB2300133	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2023-02-21					view
CYHL2300023	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2023-02-18		Hybio Pharmaceutical Co Ltd			view
CYHS2201778	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2022-10-19		Double-Crane Pharmaceutical(Hainan) Co Ltd			view
CYHS2101953	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs(4)	Generic Drug	2021-11-01		Sichuan Gowell Pharmaceutical Co Ltd			view
JYHB2101277	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2021-07-24					view
JYHB2101278	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2021-07-24					view
JYHB2002726	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2021-01-01	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Filed	2021-01-15	view
JYHB2002694	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2020-12-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-12-25	view
JYHB2002693	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2020-12-28	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	In Review	2020-12-25	view
JYHB2002063	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2020-10-16	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2020-11-05	view
JYHF2000048	利那洛肽胶囊	linaclotide	Capsule	Chemical Drugs	Supplementary Application	2020-05-06	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2020-05-26	view